Answers are grounded in this paper and cite their sources.
Our data underscores the importance of epigenomic regulation in triggering metastatic dissemination through the inactivation of central cancer-related pathways. Inactivation of cell-adhesion and differentiation unleashes dissemination, and subsequent activation of inflammatory and immune system programs impairs anti-tumoral defense pathways. Moreover, we identify several markers of tumor development and progression previously unrelated to melanoma, and determined a prognostic signature with potential clinical utility.
No takes yet. Share an insight, caveat, or question.
Wouters et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: